BriaCell Therapeutics (STU:8BT) Gross-Profit-to-Asset % : 0.00% (As of Jan. 2024)

BriaCell Therapeutics Gross-Profit-to-Asset % Chart

BriaCell Therapeutics Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
Gross-Profit-to-Asset %		Get a 7-Day Free Trial					-	-	-	-	-

BriaCell Therapeutics Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BriaCell Therapeutics's Gross-Profit-to-Asset %

For the Biotechnology subindustry, BriaCell Therapeutics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BriaCell Therapeutics's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Gross-Profit-to-Asset % falls into.

BriaCell Therapeutics Gross-Profit-to-Asset % Calculation

BriaCell Therapeutics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jul. 2023 is calculated as:

BriaCell Therapeutics's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jan. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

BriaCell Therapeutics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics (STU:8BT) Business Description